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Among the several compounds present in coffee, the coffee specific diterpenes have been identified as important 
chemo­protective agents which possess anti-carcinogenic properties.(1) Diterpenes are pentacyclic alcohols present 
in considerable quantity (up to 20%) in coffee oil.(2) Although large proportions (98%) of diterpenes exist esterified 
with various fatty acids - mainly palmitic acid, free diterpenes occur as minor components (0.7 to 3.5%).(3) Although 
there is substantial research sug-gesting the anti-carcinogenic properties of coffee diterpenes, in particular free 
cafestol and kahweol, available data regarding their anti-an-giogenic properties is still scarce. Few studies have 
demonstrated the anti-angiogenic properties of free cafestol (4) and kahweol,(5) however there is no study 
regarding the angiogenesis properties of diterpene esters, namely cafestol palmitate (CP) and kahweol palmitate 
(KP). Given that angiogenesis plays an important role in many pathological conditions, including cancer growth and 
metastasis, the present study aimed to compare and characterize whether CP and KP could inhibit angiogenesis in 
an in vitro model. For this purpose, human microvas-cular endothelial cells (HMVECs) were incubated with 50 µM 
of CP and KP. Subsequently, cell viability, cell migration, proliferation and apoptosis were assessed. In addition, 
capillary-like structures formation on Matrigel was also analysed. 
According to our findings, both compounds inhibited angiogenesis steps on HMVECs, although a more significant 
effect was observed for KP. Incubation of HMVECs at concentration of 50 µM of CP and KP, did not sustain toxic 
effects under MTS assay. However, incubation of cells with higher concentrations of CP and KP (75 and 100 µM) 
decreased cell viability significantly (p≤0.05). Compared to control, a significant anti-proliferative effects on 
HMVECs assessed by bromodeoxyuridine (BrdU) was observed for both compounds. Moreover, treatment with CP 
and KP led to impairment of migratory capacity. Nevertheless, in-rease in apoptosis as tested by double-chamber 
and terminal trans-ferase dUTP nick end labeling (TUNEL) assay was observed for CP and KP, the effect was not 
statistically significant (p≥0.05). In addition, treatment of HMVECs with CP and KP led to decrease in the assembly 
of capillary-like structures on matrigel assay.
Taken together, these data indicate that CP and KP can be considered a promising strategy against angiogenesis­
dependent disorders. Our findings further indicate that KP exerts more potent anti-angiogenic effects than CP, which may 
explain the more beneficial health effects reported for kahweol.
Referências
1. Cavin C, et al. Food and Chemical Toxicology. 2002; 40(8): 1155-63.
2. Kitzberger CSG, et al. Journal of Food Composition and Analysis. 2013; 30(1): 52-7.
R.NAC_7º Simpósio Metabolismo FMUP_180-193.indd   190 16/12/15   21:53
3  .Moeenfard M, et al. International Journal of Food Properties. 2015; 18(10): 2284-
99.
4.  Wang S, et al. Biochemical and Biophysical Research Communications 2012;
421(3): 567-71.
5. Cardenas C. A.R. PLoS One. 2011; 6(8): e23407.
